Focusing particularly on GBM, we observed that these tissues have significantly higher expression of LGALS1 in comparison to those from healthy individuals (Figure S4A) and LGALS1 levels increase with the severity of the malignancy from WHO grade II to IV (Figure S4B). The gene discussed is LGALS1; the disease is glioblastoma.